<DOC>
	<DOCNO>NCT02945904</DOCNO>
	<brief_summary>Purpose clinical trial improve prediction outcomes surgical intervention patient Primary aldosteronism , evaluate merit non-invasive metomidate PET CT versus adrenal vein sample diagnosis surgically correctable aldosteronism .</brief_summary>
	<brief_title>IS Metomidate PET-CT Superior Adrenal Venous Sampling Predicting Outcome From Adrenalectomy Patients With Primary Hyperaldosteronism</brief_title>
	<detailed_description>This observational cohort study take place within exist secondary tertiary care practice NHS . It multi-centre study participant two investigation perform random order . These follow : 11C- metomidate PET CT This one-hour non-invasive study , prior participant treat dexamethasone 3 day . Adrenal Vein Sampling This invasive investigation adrenal vein cannulate blood collect measurement adrenal steroid hormone . Adrenocorticotrophic hormone ( ACTH ) administer prior AVS order ensure steroid hormone secretion procedure . The investigator standardise start-time treatment spironolactone , first-choice treatment participant primary aldosteronism , order pre-spironolactone blood pressure biochemistry compare subsequent measurement post-surgery , change first month spironolactone treatment use ass value predict response surgery . Sub-study Repeat Metomidate PET CT Spironolactone therapy In order determine whether necessary start spironolactone treatment delayed participant investigation complete , investigator perform sub-study , early MATCH , 6 patient PET CT repeat least 6 week treatment spironolactone . ( This conventional period time spironolactone withdrawn prior AVS . ) Follow-up management investigation The investigator anticipate ~50 % participant find one investigation unilateral PA , recommend adrenalectomy . The primary outcome measurement 6 month surgery . Primary outcome : 1 . Change ARR baseline 6 month treatment 2 . Change SBP ( mean least 18 measurement 3 day ' home monitoring ) , baseline 6 month treatment Secondary outcomes 1 . Cure hypertension , define proportion patient average home blood Pressure measurements 6 month post adrenalectomy &lt; 140/90 mmHg treatment . 2 . Prediction cure hypertension , one : 1 . The ratio SUVmax tumour normal adrenal ; 2 . Blood pressure fall spironolactone ( 50 mg daily 2 week , 100 mg daily 2 week ) , measure difference home systolic blood pressure 3 . Post-operative analysis APA , include genotyping somatic mutation KCNJ5 , CACNA1D , ATP1A1 , ATP2B3 , CTNNB1 phenotyping histological grading ( zona fasciculata versus zona glomerulosa ) , gene expression immunohistochemistry . 3 . Change home blood pressure baseline follow-up visit 6 month post-adrenalectomy . 4 . Reduction number antihypertensive drug 5 . Change baseline blood level Troponin , Brain Natriuretic Peptide . The judgement patient meet primary secondary outcome make critical endpoint committee meeting every 3-6 month throughout study . The sample size calculation perform permit detection significant influence outcome small number patient available . This group patient two diagnostic technique give discordant result , estimate ~20 % total . Recruitment 140 patient across 3 centre 3 year ( &lt; 1/centre/month ) , estimate 70 proceed adrenalectomy , permit 90 % power alpha=0.01 detect superiority PET CT AVS .</detailed_description>
	<mesh_term>Hyperaldosteronism</mesh_term>
	<criteria>Male female : Age &gt; 18 yr . Diagnosis PHA base publish Endocrine Society consensus guideline . Patients enrolled/consented follow : 1 . At least one paired measurement plasma renin aldosterone , measure spironolactone , show elevated ARR . 2. either plasma aldosterone &gt; 190 pmol/L saline infusion 'spontaneous hypokalemia + plasma renin detection level + plasma aldosterone &gt; 550 pmol/L ) ' ( per Endocrine Society guidance ) 3. CT MRI scan adrenal probable definite adenoma ( ) Patients elevated ARR put forward consideration MDT exceptional case spironolactone ( fully ) withdrawn , and/or saline suppression perform , IF : 1 . Plasma Aldosterone &gt; 450 pmol/L AND plasma renin &lt; 0.5 pmol/ml/hr ( &lt; 9 mU/L ) measure treatment ACEI ( Lisinopril &gt; =20 mg equivalent ) ARB ( Losartan 100 mg equivalent ) ; OR 2 . Age &lt; 40 AND definite adrenal adenoma CT MRI Patients whose CT/MRI show probable definite adenoma must also review MDT enrolment/consent All patient positive Aldosterone renin ratio ( ARR ) serum measurement another local diagnostic confirmatory test specify local specialise APA Guidelines . This often standard crosssectional imaging CT MR scan . Any exception recommend diagnostic criterion subject approval monthly MDT . Those patient indicate unlikely proceed surgery recruit , outcome change blood pressure , restoration normal renin/angiotensin physiology ) compare accuracy two Investigations . Patients contraindicate spironolactone therapy . Any patient continue betablockers direct renin blocker . Pregnant / breastfeeding female woman unable/unwilling take secure contraceptive precaution whilst undergoing investigation . Patients unwilling/unable take dexamethasone require prepare metomidate PETCT scan . Any illness , condition drug regimen consider contraindication PI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>